We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Demonstrates State-Of-The-Art ESR Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022

ALCOR Scientific (Smithfield, RI, USA) is demonstrating its innovative diagnostic instruments and medical devices for the healthcare industry at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany. More...

At MEDICA 2022, ALCOR is presenting iSED, a 20-position, fully automated ESR analyzer that produces results in 20 seconds using just 100µL of sample taken directly from the primary EDTA tube. This small sample volume makes the iSED ideal for pediatric and low volume samples. Primary tube sampling ensures sample and result traceability and decreases biohazard risk to the user. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS.

ALCOR is also demonstrating the miniiSED, a single position, fully automated ESR analyzer that uses the same technology as the iSED in a smaller footprint. The miniiSED produces results in just 15 seconds using only 100 µL of sample taken directly from the primary EDTA tube. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS. With the small sample volume and fast turnaround time in a minimal footprint, the miniiSED is the ideal ESR analyzer for small hospital laboratories, emergency rooms, specialty testing laboratories and POLs.

Related Links:
ALCOR Scientific


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.